These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2391238)

  • 1. Report of an International Atomic Energy Agency's Advisory Group meeting on "Quality control of cyclotron-produced radiopharmaceuticals".
    Vera-Ruiz H; Marcus CS; Pike VW; Coenen HH; Fowler JS; Meyer GJ; Cox PH; Vaalburg W; Cantineau R; Helus F
    Int J Rad Appl Instrum B; 1990; 17(5):445-56. PubMed ID: 2391238
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current topics in radiopharmaceuticals in Japan. (III) Cyclotron-radiopharmaceuticals and clinical applications].
    Ido T
    Radioisotopes; 1984 Feb; 33(2):109-14. PubMed ID: 6610890
    [No Abstract]   [Full Text] [Related]  

  • 3. The International Atomic Energy Agency's work in the field of nuclear medicine.
    COHEN M; DUDLEY RA; GOMEZ-CRESPO G; PEARSON JD; TSIEN KC; VETTER H
    Nurs Outlook; 1962 Jul; 2():435-46. PubMed ID: 13880283
    [No Abstract]   [Full Text] [Related]  

  • 4. [Guidelines for evaluation of safety standards associated with hospital cyclotron-produced radiopharmaceuticals. Subcommittee on Medical Application of Cyclotron-produced Radionuclides, Medical and Pharmaceutical Committee, Japan Radioisotope Association].
    Radioisotopes; 1986 Nov; 35(11):616-8. PubMed ID: 3809614
    [No Abstract]   [Full Text] [Related]  

  • 5. EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues.
    Vander Borght T; Asenbaum S; Bartenstein P; Halldin C; Kapucu O; Van Laere K; Varrone A; Tatsch K;
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1374-80. PubMed ID: 16932934
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclotrons and positron emission tomography radiopharmaceuticals for clinical imaging.
    Saha GB; MacIntyre WJ; Go RT
    Semin Nucl Med; 1992 Jul; 22(3):150-61. PubMed ID: 1523413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDOPA PET has clinical utility in brain tumour imaging: a proposal for a revision of the recent EANM guidelines.
    Talbot JN; Kerrou K; Montravers F; Nataf V; Chevalme Y
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1131-2; author reply 1133-4. PubMed ID: 17437107
    [No Abstract]   [Full Text] [Related]  

  • 8. Experiences of fifteen years on metrological supervision of radionuclide calibrators used in nuclear medicine.
    Szörényi A; Vágvölgyi J; Zsinka A
    Appl Radiat Isot; 1998; 49(9-11):1459-61. PubMed ID: 9699295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding patient needs: congressmen aid nuclear medicine.
    Kotz D
    J Nucl Med; 1998 Nov; 39(11):16N, 21N-22N, 30N. PubMed ID: 9829563
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical application of short-life nuclides and cyclotron nuclear medicine].
    Suehiro M; Toyama H; Iio M
    Nihon Rinsho; 1981 Mar; 39(3):631-43. PubMed ID: 7021919
    [No Abstract]   [Full Text] [Related]  

  • 11. Status and plans for implementation of NRC regulatory authority for certain naturally occurring and accelerator-produced radioactive material.
    Mauer A
    J Nucl Med Technol; 2007 Jun; 35(2):112-3. PubMed ID: 17537736
    [No Abstract]   [Full Text] [Related]  

  • 12. The IAEA technical cooperation programme and nuclear medicine in the developing world: objectives, trends, and contributions.
    Casas-Zamora JA; Kashyap R
    Semin Nucl Med; 2013 May; 43(3):172-80. PubMed ID: 23561454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A report on the implementation aspects of the International Atomic Energy Agency's first doctoral coordinated research project, "Management of liver cancer using radionuclide methods with special emphasis on trans-arterial radio-conjugate therapy and internal dosimetry".
    Padhy AK; Dondi M
    Semin Nucl Med; 2008 Mar; 38(2):S5-12. PubMed ID: 18243843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In-house cyclotron and nuclear medicine].
    Tateno Y; Shishido F; Yamazaki T
    Rinsho Hoshasen; 1982 Nov; 27(12):1309-17. PubMed ID: 6984470
    [No Abstract]   [Full Text] [Related]  

  • 15. Congressional subcommittee scrutinizes looming U.S. radioisotope supply crisis.
    Rojas-Burke J
    J Nucl Med; 1992 Oct; 33(10):16N, 21N-22N, 34N. PubMed ID: 1403135
    [No Abstract]   [Full Text] [Related]  

  • 16. Transportation of short-lived positron emitters from a medical cyclotron to a remote imaging suite.
    Correia JA; Bucelewicz WH; Strauss HW; Alpert NM; Brownell GL; Taveras JM; Ferrari V
    Med Phys; 1983; 10(2):228-31. PubMed ID: 6602938
    [No Abstract]   [Full Text] [Related]  

  • 17. IAEA support to medical physics in nuclear medicine.
    Meghzifene A; Sgouros G
    Semin Nucl Med; 2013 May; 43(3):181-7. PubMed ID: 23561455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The medical case for an Australian national cyclotron facility.
    Morris JG; Boyd RE; Smith RS; Hardy CJ; Towson JE; Bautovich GJ; Hutton BF
    Med J Aust; 1985 Apr; 142(8):454-7. PubMed ID: 3872404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medium half-life radionuclides for medical use].
    Guillaume M
    Rev Med Liege; 1980 Sep; 35(17):587-97. PubMed ID: 7455438
    [No Abstract]   [Full Text] [Related]  

  • 20. Society sues NRC over radiopharmacy rule.
    Kotz D
    J Nucl Med; 1995 Mar; 36(3):14N-15N, 20N-21N. PubMed ID: 7884491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.